A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
Clinical trial NCT05354089 · UNKNOWN
Trial details
- NCT number
- NCT05354089
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2022-07-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.